These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 28544873

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N, Lecanu L, Greeson J, Papadopoulos V.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6277-80. PubMed ID: 17049234
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S, Barron MG.
    Toxicol Sci; 2015 Nov 15; 148(1):60-70. PubMed ID: 26202430
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors.
    Liu A, Guang H, Zhu L, Du G, Lee SM, Wang Y.
    Sci China C Life Sci; 2007 Dec 15; 50(6):726-30. PubMed ID: 17914643
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB, Aguan K, Mitra S, Bhattacharjee A.
    J Biomol Struct Dyn; 2017 Jun 15; 35(8):1729-1742. PubMed ID: 27410776
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
    Shen LL, Liu GX, Tang Y.
    Acta Pharmacol Sin; 2007 Dec 15; 28(12):2053-63. PubMed ID: 18031622
    [Abstract] [Full Text] [Related]

  • 14. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening.
    Valasani KR, Chaney MO, Day VW, Shidu Yan S.
    J Chem Inf Model; 2013 Aug 26; 53(8):2033-46. PubMed ID: 23777291
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A, Hu J, Wang L, Zhong G, Pan J, Wu Z, Hui A.
    J Mol Model; 2015 Oct 26; 21(10):277. PubMed ID: 26438408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer's Disease.
    Pulikkal BP, Marunnan SM, Bandaru S, Yadav M, Nayarisseri A, Sureshkumar S.
    Curr Neuropharmacol; 2017 Nov 14; 15(8):1093-1099. PubMed ID: 27964704
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.